Literature DB >> 20500137

In rural Tibet, the prevalence of lower limb pain, especially knee pain, is high: an observational study.

Damian G Hoy1, Marlene Fransen, Lyn March, Peter Brooks, Joanne Durham, Michael J Toole.   

Abstract

QUESTION: What is the point prevalence and 12-month prevalence of lower limb musculoskeletal pain in rural Tibet? Does this differ with gender or age? What factors that could contribute to lower limb musculoskeletal pain are commonly present?
DESIGN: Observational study using an investigator-administered questionnaire and observation walks through villages. PARTICIPANTS: 499 people aged 15 years and over living in 19 rural villages of Shigatse Municipality, Tibet.
RESULTS: The point prevalence of lower limb musculoskeletal pain was 40% (95% CI 34 to 46) while the 12-month prevalence was 48% (95% CI 42 to 54). In particular, the point prevalence of knee pain was 25% (95% CI 20 to 30) and the 12-month prevalence was 29% (95% CI 23 to 35), which was significantly higher than at any other site in the lower limb. On average, being female was not associated with lower limb musculoskeletal pain either currently (OR 1.3, 95% CI 0.9 to 1.9) or over the previous 12 months (OR 1.2, 95% CI 0.9 to 1.8), whereas being older than 50 years was, both for current pain (OR 4.1, 95% CI 2.8 to 6.1) and pain over the previous 12 months (OR 4.0, 95% CI 2.7 to 6.0). Observation walks through the villages revealed people squatting for sustained periods, carrying heavy loads for long distances, wearing poor quality footwear, and with severe bowing of the legs but no obesity.
CONCLUSION: Lower limb musculoskeletal pain, particularly knee pain, is common in this rural Tibetan population. They live an extremely arduous life that appears to place considerable pressure on their knees.

Entities:  

Mesh:

Year:  2010        PMID: 20500137     DOI: 10.1016/s1836-9553(10)70054-0

Source DB:  PubMed          Journal:  J Physiother        ISSN: 1836-9561            Impact factor:   7.000


  6 in total

1.  The Constellation of Chronic Low Back Pain and Other Subjective Symptoms: Does the View Differ From China?

Authors:  Ernest Volinn; Bangxiang Yang; Nan Chen; Jian Ying; Jing Lin; Xiaoming Sheng; Yunxia Zuo
Journal:  Spine (Phila Pa 1976)       Date:  2016-04       Impact factor: 3.468

2.  Epidemiology of knee osteoarthritis using Kellgren and Lawrence scale in Indian population.

Authors:  Harish Kumar; Chandra P Pal; Yajuvendra Kumar Sharma; Sandeep Kumar; Arjun Uppal
Journal:  J Clin Orthop Trauma       Date:  2019-05-24

3.  Epidemiology of knee osteoarthritis in India and related factors.

Authors:  Chandra Prakash Pal; Pulkesh Singh; Sanjay Chaturvedi; Kaushal Kumar Pruthi; Ashok Vij
Journal:  Indian J Orthop       Date:  2016-09       Impact factor: 1.251

4.  Arthritis diagnosis and symptoms are positively associated with specific physical job exposures in lower- and middle-income countries: cross-sectional results from the World Health Organization's Study on global AGEing and adult health (SAGE).

Authors:  Sharon L Brennan-Olsen; Svetlana Solovieva; Eira Viikari-Juntura; Ilana N Ackerman; Steven J Bowe; Paul Kowal; Nirmala Naidoo; Somnath Chatterji; Anita E Wluka; Michelle T Leech; Richard S Page; Kerrie M Sanders; Fernando Gomez; Gustavo Duque; Darci Green; Mohammadreza Mohebbi
Journal:  BMC Public Health       Date:  2018-06-08       Impact factor: 3.295

5.  Use of The Global Alliance for Musculoskeletal Health survey module for estimating the population prevalence of musculoskeletal pain: findings from the Solomon Islands.

Authors:  D G Hoy; T Raikoti; E Smith; A Tuzakana; T Gill; K Matikarai; J Tako; A Jorari; F Blyth; A Pitaboe; R Buchbinder; I Kalauma; P Brooks; C Lepers; A Woolf; A Briggs; L March
Journal:  BMC Musculoskelet Disord       Date:  2018-08-16       Impact factor: 2.362

Review 6.  Risk factors for chronic disease in Viet Nam: a review of the literature.

Authors:  Damian Hoy; Chalapati Rao; Nguyen Thi Trang Nhung; Geoffrey Marks; Nguyen Phuong Hoa
Journal:  Prev Chronic Dis       Date:  2013       Impact factor: 2.830

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.